Post-graduate degree (BS-MS, MSc, M.Tech) in Biological Sciences, Biotechnology, Botany, Life Sciences, Plant Sciences or related subjects with a minimum of 60% marks
Masters degree in any branch of Life Sciences from a recognized university with two years of post- qualification experience in molecular biology and biochemistry.
Master degree in life sciences or biotechnology, or molecular biology or genetics (1st Class) from a recognized university with 2 years research experience in relevant project
Post Graduate Degree, including the integrated PG degree, in Life Sciences from a recognized university with three years of post-qualification experience in molecular biology, biochemistry
State of the art laboratory infrastructure to support and promote high quality as well as interdisciplinary research in different pure and applied areas. Support to set up collaborative research.
Proficient in testing raw materials, finished products, and stability samples for Nasal formulations. Knowledge of method validation, calibration, and qualification activities.
Responsible for Preparation of Regulatory Documents for submission to Indian Regulatory Authorities. Experienced in handling, management and expansion of product portfolios, markets/ territories.
Immacule Lifesciences Pvt. Ltd. is expanding and looking for passionate professionals with Regulatory Exposure and Sterile Experience to join our growing team.
Responsible for investigations related to Laboratory incidents, OOS, OOT, OOE, failure investigations and participating / involving in these investigations
B.Pharm / M.Pharm / BSc / MSc; Lactose India Limited is a young and innovative company specializing in the manufacturing of Excipients Lactose / Colour Coatings, Lactulose, Solid Dosage Forms, Liquid Dosage Forms, at Vadodara, Gujarat.
Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing and commercializing high-quality medicines, announced that its fourth Phase 3 clinical trial, DREAMS-3, evaluating mazdutide, a dual glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptor agonist met its primary endpoint.
Dr Reddys Laboratories Ltd, one of Indias leading pharmaceutical companies, plans to launch a lower-cost generic version of Novo Nordisks blockbuster weight-loss drug Wegovy across 87 countries next year, according to the company’s Chief Executive Officer, Erez Israeli.
GSK plc announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory (IMID) agent.
Avidity is committed to delivering a new class of pioneering RNA therapeutics called Antibody Oligonucleotide Conjugates for serious, genetic neuromuscular diseases. The proposed acquisition will bring Aviditys late-stage neuroscience programs into Novartis and provide Novartis access to a differentiated RNA-targeting delivery platform.
Pharmacist Officers under the Central/State/U.T. Governments/ Universities/Statutory Bodies or Autonomous Bodies or Research and Development Organizations
Applications are invited from eligible and qualified candidates for engagement as Guest Faculty On Hourly Basis / Paper wise to teach B.Pharm., and M.Pharm at Satavahana University
BPharm/MBBS/lntegrated BS- MS/MSc/BE/BTech or equivalent degree at AIIMS Rishikesh. To investigate the association of metalloestrogen and epigenetic changes in ovarian endometriosis: An exploratory and in- vitro study